Rheumatoid arthritis-celiac disease relationship: Joints get that gut feeling

Autoimmunity Reviews

Volumn 14, Issue 11, 2015, Pages 1038-1047

  Lerner, Aaron ^a   Matthias, Torsten ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b AESKUKIPP Institute   (Germany)

Author keywords

Celiac disease; Dysbiosis; Environmental factors; Intestinal permeability; Rheumatoid arthritis; Tissue transglutaminase

Indexed keywords

ANTIGEN; AUTOANTIBODY; INTESTINE ENZYME;

ANKYLOSING SPONDYLITIS; ANTIBODY PRODUCTION; ARTHRALGIA; ARTHRITIS; BACKACHE; CASE REPORT; CELIAC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSBIOSIS; ENTHESOPATHY; ENVIRONMENTAL FACTOR; GASTROINTESTINAL DISEASE; HEREDITY; HUMAN; INCIDENCE; INFECTION; INTESTINE MUCOSA PERMEABILITY; JOINT STIFFNESS; NUTRITION; OSTEOARTHRITIS; PATHOGENESIS; PREVALENCE; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SACROILIITIS; SYNOVITIS; ANIMAL; DIET; IMMUNOLOGY; INTESTINE; METABOLISM;

ANIMALS; ANTIGENS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CELIAC DISEASE; DIET; HUMANS; INTESTINES;

EID: 84941260183     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.07.007     Document Type: Review

References (134)

1. Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care 2014, 20:S128-S135.
2. Ferrari M., Onuoha S.C., Pitzalis C. Trojan horses and guided missiles: targeted therapies in the war on arthritis. Nat Rev Rheumato Mar. 3, 2015, [Epub ahead of print]. 10.1038/nrrheum.2015.17.
3. Jutley G., Raza K., Buckley C.D. New pathogenic insights into rheumatoid arthritis. Curr Opin Rheumatol 2015, 27:249-255.
4. Demoruelle M.K., Deane K.D., Holers V.M. When and where does inflammation begin in rheumatoid arthritis?. Curr Opin Rheumatol 2014, 26:64-71.
5. Brusca S.B., Abramson S.B., Scher J.U. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 2014, 26:101-107.
6. Denham J.M., Hill I.D. Celiac disease and autoimmunity: review and controversies. Curr Allergy Asthma Rep 2013, 13:347-353.
7. Tonutti E., Bizzaro N. Diagnosis and classification of celiac disease and gluten sensitivity. Autoimmun Rev 2014, 13:472-476.
8. Lerner A. Serological diagnosis of celiac disease - moving beyond the tip of the iceberg. Int J Celiac Dis 2014, 2:64-66.
9. Lerner A., Agmon-Levin N., Shapira Y., Gilburd B., Reuter S., Lavi L., et al. The thrombophylic network of autoantibodies in celiac disease. BMJ Med 2013, 11:89-95.
10. Lerner A., Blank M. Hypercoagulability in celiac disease-an update. Autoimmun Rev 2014, 13:1138-1141.
11. Lerner A., Matthias T. Celiac disease: intestinal, heart and skin inter-connections. Int J Celiac Dis 2015, 3:28-30.
12. Severance E.G., Yolken R.H., Eaton W.W. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res Jul. 14, 2014, [pii: S0920-9964(14)00319-3], [Epub ahead of print]. 10.1016/j.schres.2014.06.027.
13. Lerner A. New therapeutic strategies for celiac disease. Autoimmun Rev 2010, 9:144-147.
14. Bashi T., Bizzaro G., Ben-Ami Shor D., Blank M., Shoenfeld Y. The mechanisms behind helminth's immunomodulation in autoimmunity. Autoimmun Rev 2015, 14:98-104.
15. Hemminki K., Li X., Sundquist K., Sundquist J. Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum 2009, 60:2845-2847.
16. Konturek P.C., Brzozowski T., Konturek S.J. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 2011, 62:591-599.
17. Xu Q., Guo X., Liu J., Chen B., Liu Z., Su L. Blockage of protease-activated receptor 1 ameliorates heat-stress induced intestinal high permeability and bacterial translocation. Cell Biol Int Dec. 9, 2015, 39:411-417.
18. Ciacci C., Siniscalchi M., Bucci C., Zingone F., Morra I., Iovino P. Life events and the onset of celiac disease from a patient's perspective. Nutrients 2013, 5:3388-3398.
19. Fogarty F.A., Booth R.J., Gamble G.D., Dalbeth N., Consedine N.S. The effect of mindfulness-based stress reduction on disease activity in people with rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 2015, 74:472-474.
20. Li S., Yu Y., Yue Y., Zhang Z., Su K. Microbial infection and rheumatoid arthritis. J Clin Cell Immuno 2013, 4. [pii: 174.].
21. Pérez-Barbosa L., Esquivel-Valerio J.A., Arana-Guajardo A.C., Vega-Morales D., Riega-Torres J., Garza-Elizondo M.A. Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients. Rheumatol Int Mar 14 2015, [Epub ahead of print].
22. Sandberg M.E., Bengtsson C., Klareskog L., Alfredsson L., Saevarsdottir S. Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study. Ann Rheum Dis Feb 5 2015, 74:904-907.
23. Lerner A., Reif S. Nonnutritional environmental factors associated with celiac disease: the infectome. Infections and autoimmunity 2015, 829-837. Elsevier B.V., [Chapter 50]. 2nd Ed. Y. Shoenfeld, N. Agmon-Levine, N.R. Rose (Eds.).
24. Machado Ribeiro F., Goldenberg T. Mycobacteria and autoimmunity. Lupus 2015, 24:374-381.
25. Draborg A.H., Duus K., Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol 2013, 2013:535738.
26. Zignego A.L., Gragnani L., Piluso A., Sebastiani M., Giuggioli D., Fallahi P., et al. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol 2015, 11:15-31.
27. Vojdani A. A Potential link between environmental triggers and autoimmunity. Autoimmune Dis 2014, 2014. [437231].
28. Picascia A., Grimaldi V., Pignalosa O., De Pascale M.R., Schiano C., Napoli C. Epigenetic control of autoimmune diseases: from bench to bedside. Clin Immunol 2015, 157:1-15.
29. Singh R.P., Massachi I., Manickavel S., Singh S., Rao N.P., Hasan S., et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 2013, 12:1160-1165.
30. D'Aurizio F., Villalta D., Metus P., Doretto P., Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases?. Autoimmun Rev 2015, 14:363-369.
31. Bonaventura P., Benedetti G., Albarède F., Miossec P. Zinc and its role in immunity and inflammation. Autoimmun Rev 2015, 14:277-285.
32. Lerner A., Jeremias P., Matthias T. The world incidence of celiac disease is increasing: a review. Internat J of Recent Scientific Res 2015, [In press].
33. Peschken C.A., Hitchon C.A. Rising prevalence of autoimmune rheumatic Disease: increased awareness, increased disease or increased survival?. Arth Res &Ther 2012, 14(Suppl. 3):8-9.
34. Lauret E., Rodrigo L. Celiac disease and autoimmune-associated conditions. Biomed Res Int 2013, 2013. [127589].
35. Hemminki K., Li X., Sundquist J., Sundquist K. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009, 60:661-668.
36. Jiang X., Frisell T., Askling J., Karlson E.W., Klareskog L., Alfredsson L., et al. To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?. Arthritis Rheum. 2015, 67:352-362.
37. Frisell T., Holmqvist M., Källberg H., Klareskog L., Alfredsson L., Askling J. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age. Arthritis Rheum 2013, 65:2773-2782.
38. Uenishi R.H., Gandolfi L., Almeida L.M., Fritsch P.M., Almeida F.C., Nóbrega Y.K., et al. Screening for celiac disease in 1st degree relatives: a 10-year follow-up study. BMC Gastroenterol 2014, 14:36-41.
39. Emilsson L., Wijmenga C., Murray J.A., Ludvigsson J.F. Autoimmune disease in first-degree relatives and spouses of individuals with celiac disease. Clin Gastroenterol Hepatol Jan 31 2015, 13:1271-1277.
40. Shaoul R., Lerner A. Associated autoantibodies in celiac disease. Autoimmun Rev 2007, 6:559-565.
41. Steiner G. Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin Rev Allergy Immunol 2007, 32:23-36.
42. Shor D.B., Orbach H., Boaz M., Altman A., Anaya J.M., Bizzaro N., et al. Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol 2012, 1:49-55.
43. Koehne Vde B., Bahia M., Lanna C.C., Pinto M.R., Bambirra E.A., Cunha A.S. Prevalence of serological markers for celiac disease (IgA and IgG class antigliadin antibodies and IgA class antiendomysium antibodies) in patients with autoimmune rheumatologic diseases in Belo Horizonte, MG, Brazil. Arq Gastroenterol 2010, 47:250-256.
44. Skare T., Nisihara R.M., Utiyama S.R. Is it worth investigating coeliac disease in patients with rheumatic disorders?. Rheumatology (Oxford) 2013, 52:217-218.
45. Roth E.B., Stenberg P., Book C., Sjöberg K. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis-new pathways to epitope spreading. Clin Exp Rheumatol 2006, 24:12-18.
46. Stoll M.L., Pate A.S., Christadoss M.L., Punaro M., Olsen N.J. IgA transglutaminase levels in children with Juvenile Idiopathic arthritis. Ann Paediatr Rheumatol 2012, 1:31-35.
47. Lerner A., Matthias T. Transient anti TG2 autoantibodies in systemic lupus erythematosus: a window to autoimmunity. Int J Celiac Dis 2015, 3:72-74.
48. Song K.S., Choi J.R. Tissue transglutaminase autoantibodies in patients with IgM rheumatoid factors. Yonsei Med J 2004, 45:960-962.
49. Hällgren J., Knutson F., Lavö B., Hällgren R. Increased mucosal synthesis of rheumatoid factor (RF) in coeliac disease. Clin Exp Immunol 1996, 103:94-98.
50. Feighery L., Collins C., Feighery C., Mahmud N., Coughlan G., Willoughby R., et al. Anti-transglutaminase antibodies and the serological diagnosis of coeliac disease. Br J Biomed Sci 2003, 60:14-18.
51. Liao K.P., Kurreeman F., Li G., Duclos G. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. Arthritis Rheum 2013, 65:571-581.
52. Gheita T.A., Fawzy S.M. Aymptomtic celiac sprue in juvenile rheumatic diseases children. Int J Rheum Dis 2012, 15:220-226.
53. Rozenberg O., Lerner A., Pacht A., Grinberg M., Reginashvili D., Henig C., et al. A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics. Clin Rev Allergy Immunol 2012, 42:331-341.
54. Rozenberg O., Lerner A., Pacht A., Grinberg M., Reginashvili D., Henig C., et al. A new algorithm for the diagnosis of celiac disease. Cell Mol Immunol 2011, 8:146-149.
55. Barak M., Rozenberg O., Froom P., Grinberg M., Reginashvili D., Henig C., et al. Challenging our serological algorithm for celiac disease (CD) diagnosis by the ESPGHAN guidelines. Clin Chem Lab Med 2013, 51:e257-e259.
56. Lerner A., Matthias T. Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis. Nutr Rev. Jun 16 2015, 73:544-552.
57. Lerner A., Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun. Rev. 2015, 14:479-489.
58. Greiner A., Plischke H., Kellner H., Gruber R. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad of Sci 2005, 1050:295-303.
59. Jilani A.A., Mackworth-Young C.G. The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol 2015, 2015. [728610].
60. Pratesi F., Petit Teixeira E., Sidney J., Michou L., Puxeddu I., Sette A., et al. HLA shared epitope and ACPA: just a marker or an active player?. Autoimmun Rev 2013, 12:1182-1187.
61. Valesini G., Gerardi M.C., Iannuccelli C., Pacucci V.A., Pendolino M., Shoenfeld Y. Citrullination and autoimmunity. Autoimmun Rev 2015, 14:490-497.
62. Toes E.M., Huizinga J.W. Update on autoantibodies to modified proteins. Curr Opin Rheumatol 2015, 27:262-267.
63. Ioannou H.P., Fotoulaki M., Pavlitou A., Efstratiou I., Augoustides-Savvopoulou P. Plasma citrulline levels in paediatric patients with celiac disease and the effect of a gluten-free diet. Eur J Gastroenterol Hepatol 2011, 23:245-249.
64. Crenn P., Messing B., Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008, 27:328-339.
65. Lubrano E., Ciacci C., Ames P.R., Mazzacca G., Oriente P., Scarpa R. The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol 1996, 35:1314-1318.
66. Bourne J.T., Kumar P., Huskisson E.C., Mageed Unsworth D.J., Wojtulewski J.A. Arthritis and coeliac disease. Ann Rheum Dis 1985, 44:592-598.
67. Ghozzi M., Sakly W., Mankaï A., Bouajina E., Bahri F., Nouira R., et al. Screening for celiac disease, by endomysial antibodies, in patients with unexplained articular manifestations. Rheumatol Int 2014, 34:637-642.
68. Iagnocco A., Ceccarelli F., Mennini M., Rutigliano I.M., Perricone C., Nenna R., et al. Subclinical synovitis detected by ultrasound in children affected by coeliac disease: a frequent manifestation improved by a gluten-free diet. Clin Exp Rheumatol 2014, 32:137-142.
69. Atteno M., Costa L., Tortora R., Cozzolino A., Del Puente A., Caso F., et al. The occurrence of lower limb enthesopathy in coeliac disease patients without clinical signs of articular involvement. Rheumatology (Oxford) 2013, 52:893-897.
70. Vereckei E., Mester A., Hodinka L., Temesvári P., Kiss E., Poór G. Back pain and sacroiliitis in long-standing adult celiac disease: a cross-sectional and follow-up study. Rheumatol Int 2010, 30:455-460.
71. Dawidowicz K., Ea H.K., Lahalle S., Qubaja M., Lioté F. Unexplained polyarthralgia and celiac disease. Joint Bone Spine 2008, 75:325-328.
72. Basavaraju K.P., Rahman N., Neal D.A. Is an atypical presentation becoming typical of coeliac disease?. BMJ Case Rep 2009, 2009. bcr06.2008.0169.
73. Usai P., Boi M.F., Piga M., Cacace E., Lai M.A., Beccaris A., et al. Adult celiac disease is frequently associated with sacroiliitis. Dig Dis Sci 1995, 40:1906-1908.
74. Slot O., Locht H. Arthritis as presenting symptom in silent adult coeliac disease. Two cases and review of the literature. Scand J Rheumatol 2000, 29:260-263.
75. Iqbal T., Zaidi M.A., Wells G.A., Karsh J. Celiac disease arthropathy and autoimmunity study. J Gastroenterol Hepatol 2013, 28:99-105.
76. De Maddi F., Pellegrini F., Raffaele C.G., Tarantino G., Rigante D. Celiac disease and juvenile idiopathic arthritis: a still enigmatic crossover. Scand J Gastroenterol 2013, 48:511-512.
77. Collin P., Korpela M., Hällström O., Viander M., Keyriläinen O., Mäki M. Rheumatic complaints as a presenting symptom in patients with coeliac disease. Scand J Rheumatol 1992, 21:20-23.
78. Kumar S., Gupta N., Jhamb R., Mishra D. Celiac disease: association with adult-onset Still's disease: apropos of a clinical case. Indian J Med Sci 2007, 61:414-417.
79. Carli P., Chagnon A., Harlé J.R., Paris J.F., Marlier S., Galzin M. Inflammatory rheumatism and celiac disease in adults. Coincidence or pathogenic relationship?. Press Med 1995, 24:606-610.
80. Ejsing-Duun M., Josephsen J., Aasted B., Buschard K., Hansen A.K. Dietary gluten reduces the number of intestinal regulatory T cells in mice. Scand J Immunol 2008, 67:553-559.
81. Larsen J., Weile C., Antvorskov J.C., Engkilde K., Nielsen S.M., Josefsen K., et al. Effect of dietary gluten on dendritic cells and innate immune subsets in BALB/c and NOD mice. PLoS One 2015, 10. [e0118618].
82. Marietta E.V., Gomez A.M., Yeoman C., Tilahun A.Y., Clark C.R., Luckey D.H., et al. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One 2013, 8. [e78687].
83. Adlercreutz E.H., Weile C., Larsen J., Engkilde K., Agardh D., Buschard K., et al. A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice. Clin Exp Immunol 2014, 177:391-403.
84. Larsen J., Dall M., Antvorskov J.C., Weile C., Engkilde K., Josefsen K., et al. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur J Immunol 2014, 44:3056-3067.
85. Antvorskov J., Josefsen K., Engkilde K., Funda D.P., Buschard K. Dietary gluten and the development of type 1 diabetes. Diabetologia 2014, 57:1770-1780.
86. Beitnes A.C., Ráki M., Brottveit M., Lundin K.E., Jahnsen F.L., Sollid L.M. Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge. PLoS One 2012, 7. [e33556].
87. Ferretti G., Bacchetti T., Masciangelo S., Saturni L. Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. Nutrients 2012, 4:243-257.
88. Brottveit M., Beitnes A.C., Tollefsen S., Bratlie J.E., Jahnsen F.L., Johansen F.E., et al. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol 2013, 108:842-850.
89. Bucci C., Zingone F., Russo I., Morra I., Tortora R., Pogna N., et al. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity. Clin Gastroenterol Hepatol 2013, 11:1294-1299.
90. Hollon J., Puppa E.L., Greenwald B., Goldberg E., Guerrerio A., Fasano A. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients 2015, 7:1565-1576.
91. Cosnes J., Cellier C., Viola S., Colombel J.F., Michaud L., Sarles J., et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008, 7:753-758.
92. Handa O., Naito Y., Fukui A., Omatsu T., Yoshikawa T. The impact of non-steroidal anti-inflammatory drugs on the small intestinal epithelium. J Clin Biochem Nutr 2014, 54:2-6.
93. Ebert E.C., Hagspiel K.D. Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Dig Dis Sci 2011, 56:295-302.
94. Smedslund G., Byfuglien M.G., Olsen S.U., Hagen K.B. Effectiveness and safety of dietary interventions for rheumatoid arthritis: a systematic review of randomized controlled trials. J Am Diet Assoc 2010, 110:727-735.
95. Elka A.C., Sjöberg B., Kolsrud B., Ringertz B., Hafström I., Frostegård J. Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study. Arthritis Res Ther 2008, 10:R34.
96. Hafström I., Ringertz B., Spångberg A., von Zweigbergk L., Brannemark S., Nylander I., et al. A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology (Oxford) 2001, 40:1175-1179.
97. De Vos M., Mielants H., Cuvelier C., Elewaut Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996, 110:1696-1703.
98. Mielants H., De Vos M., Goemaere S., Schelstraete K., Cuvelier C., Goethals K., et al. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease. J Rheumatol 1991, 18:394-400.
99. Asquith M., Elewaut D., Lin P., Rosenbaum J.T. The role of the gut and microbes in the pathogenesis of spondyloarthritis. Best Pract Res Clin Rheumatol 2014, 28:687-702.
100. Plot L., Amital H., Barzilai O., Ram M., Bizzaro N., Shoenfeld Y. Infections may have a protective role in the etiopathogenesis of celiac disease. Ann N Y Acad Sci 2009, 1173:670-674.
101. Croese J., Giacomin P., Navarro S., Clouston A., McCann L., Dougall A., et al. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J Allergy Clin Immunol 2015, 135:508-516.
102. Pineda M.A., Eason R.J., Harnett M.M., Harnett W. From the worm to the pill, the parasitic worm product ES-62 raises new horizons in the treatment of rheumatoid arthritis. Lupus 2015, 24:400-411.
103. Tian N., Wei G., Schuppan D., Helmerhorst E.J. Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease. Am J Physiol Gastrointest Liver Physiol 2014, 307:G769-G776.
104. Al-Okbi S.Y. Nutraceuticals of anti-inflammatory activity as complementary therapy for rheumatoid arthritis. Toxicol Ind Health 2014, 30:738-749.
105. García-González A., Gaxiola-Robles R., Zenteno-Savín T. Oxidative stress in patients with rheumatoid arthritis. Rev Invest Clin 2015, 67:46-53.
106. Jalili M., Kolahi S., Aref-Hosseini S.R., Mamegani M.E., Hekmatdoost A. Beneficial role of antioxidants on clinical outcomes and erythrocyte antioxidant parameters in rheumatoid arthritis patients. Int J Prev Med 2014, 5:835-840.
107. Di Giuseppe D., Wallin A., Bottai M., Askling J., Wolk A. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum Dis 2014, 73:1949-1953.
108. Linauskas A., de Thurah A., Andersen G.N., Stengaard-Pedersen K. No evidence that diet has any influence on the aetiology of rheumatoid arthritis. Ugeskr Laeger 2015, 13:177.
109. Viladomiu M., Hontecillas R., Yuan L., Lu P., Bassaganya-Riera J. Nutritional protective mechanisms against gut inflammation. J Nutr Biochem 2013, 24:929-939.
110. Campbell A.W. Autoimmunity and the gut. Autoimmune Dis 2014, 2014. [152428].
111. Scher J.U., Bretz W.A., Abramson S.B. Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?. Curr Opin Rheumatol. 2014, 26:424-429.
112. Bernard N.J. Rheumatoid arthritis: Prevotella copri associated with new-onset untreated RA. Nat Rev Rheumatol 2014, 10:2.
113. Terato K., Do C.T., Shionoya H. Slipping through the cracks: linking low immune function and intestinal bacterial imbalance to the etiology of rheumatoid arthritis. Autoimmune Dis 2015, 2015. [636207].
114. Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270.
115. Luckey D., Gomez A., Murray J., White B., Taneja V. Bugs & us: the role of the gut in autoimmunity. Indian J Med Res 2013, 138:732-743.
116. Rostami Nejad M., Ishaq S., Al Dulaimi D., Zali M.R., Rostami K. The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease. Arch Iran Med 2015, 18:244-249.
117. Carding S., Verbeke K., Vipond D.T., Corfe B.M., Owen L.J. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 2015, 26. [26191].
118. Sjöberg V., Sandström O., Hedberg M., Hammarström S., Hernell O., Hammarström M.L. Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria. PLoS One 2013, 8. [e53414].
119. Yoshida K., Korchynskyi O., Tak P.P., Isozaki T., Ruth J.H., Campbell P.L., et al. Citrullination of epithelial neutrophil-activating peptide 78/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine. Arthritis Rheum 2014, 66:2716-2727.
120. Lerner A., Matthias T. Food Industrial microbial transglutaminase in celiac disease: treat or trick. J Celiac Dis 2015, 3:1-6.
121. Sollid L.M., Jabri B. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol 2011, 23:732-738.
122. Poon I.K., Lucas C.D., Rossi A.G., Ravichandran S. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 2014, 14:166-180.
123. Cupi M.L., Sarra M., De Nitto D., Franzè E., Marafini I., Monteleone I., et al. Defective expression of scavenger receptors in celiac disease mucosa. PLoS One 2014, 9. [e100980].
124. Rauhavirta T., Lindfors K., Koskinen O., Laurila K., Kurppa K., Saavalainen P., et al. Impaired epithelial integrity in the duodenal mucosa in early stages of celiac disease. Transl Res 2014, 164:223-231.
125. Lauzier A., Charbonneau M., Paquette M., Harper K., Dubois C.M. Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis. Arthritis Res Ther 2012, 14:R159.
126. Picco P., Gattorno M., Marchese N., Vignola S., Sormani M.P., Barabino A., et al. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 2000, 18:773-778.
127. Lopetuso L.R., Scaldaferri F., Bruno G., Petito V., Franceschi F., Gasbarrini A. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. Eur Rev Med Pharmacol Sci 2015, 19:1068-1076.
128. Koning F., Thomas R., Rossjohn J., Toes R.E. Coeliac disease and rheumatoid arthritis: common mechanisms, different antigens. Nat Rev Rheumatol 2015, [In press].
129. Plaza-Izurieta L., Fernandez-Jimenez N., Irastorza I., Jauregi-Miguel A., Romero-Garmendia I., Vitoria J.C., et al. Expression analysis in intestinal mucosa reveals complex relations among genes under the association peaks in celiac disease. Eur J Hum Genet Nov 12 2015, 23:1100-1105.
130. Korczowska I. Rheumatoid arthritis susceptibility genes: an overview. World J Orthop 2014, 5:544-549.
131. Zheng J., Petersen F., Yu X. The role of PTPN22 in autoimmunity: learning from mice. Autoimmun Rev 2014, 13:266-271.
132. Richard-Miceli C., Criswell L.A. Emerging patterns of genetic overlap across autoimmune disorders. Genome Med 2014, 4:6.
133. Gutierrez-Achury J., Coutinho de Almeida R., Wijmenga C. Shared genetics in coeliac disease and other immune-mediated diseases. J Intern Med 2011, 269:591-603.
134. Zhernakova A., Stahl E.A., Trynka G., Raychaudhuri S., Festen E.A., Franke L., et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011, 7. [e1002004].